Pages

Sunday, 28 January 2018

Market Insight - Dow, Dow Futures, Hangseng, SGX Nifty & Nikkei 29 Jan 17

Markets always tend to be interesting with something or the other happening all the time. Our Morning Mantra is released before the opening bell and it includes the market commentary along with Corporate & Global news for the day.

U.S. stock-market indexes closed at records on Friday, up 0.9% on the back of strong corporate earnings.



Dow
26616.7
223.9
0.85%
Dow Futures
26665.0
61.0
0.23%
Hangseng
33289.4
135.2
0.41%
Nikkei
23749.3
117.5
0.50%
SGX Nifty
11069.5
-6.5
-0.06%

Asian indices advanced today morning backed by strong global economic growth.
Market is expected to open positive note and likely to witness up move during the day.  
Future supply chain solutions buys Vulcan Express from Snapdeal.
Vakrangee announces alliance with Cinestaan Digital.
Deepak Nitrite fixes issue price of QIP at Rs 264.
Kokuyu Camlin to wind up Camlin International.
Bharat Forge sets up unit in Israel.
Havells to set up a new facility to manufacture consumer durables in Rajasthan for a total investment of Rs 360 crore.
APL Apollo Tubes terminates JV with One to One Holdings PTE.
Prataap Snacks signs new pact for third party manufacturing of potato chips at 3 places.
Raymond to buy 26% in Shahane solar power.
FDC gets GMP nod from U.K. regulators for its Ophthalmic manufacturing facility at Waluj, Aurangabad.
Andhra Bank to sell SEL manufacturing loan to ARCs.
Newgen Software Technologies Ltd will be listing today. The issue price was Rs. 245 per share.
Vedanta has been awarded two bauxite mines by the state government, a top official said, confirming the move. The two mines with 15 mtpa bauxite reserves can take care of 75% of Vedanta's needs of 20 mtpa. "We have been pleading with the state for a long time. They have always been proactive. Now finally we can ramp up production and then expand the total capacity. I am very hopeful that the worst is over for us," Agarwal said, confirming the development in an exclusive interview with ETin Davos. Positive.
Nirmal Bang Retail Research - Rane Madras reported result ahead of expectation with 30% yoy sales growth and 120 bps margin expansion on QoQ basis mainly driven by expansion on gross margin. Interest cost decline on account of repayment of loan from Prefrontal allotment money. We have revised our earning expectation with consolidated Sales/ EBITDA /PAT for FY19 and FY20 at Rs.1430cr/ 141cr/Rs.35cr and Rs.1623cr/ 175cr/ 61cr respectively. We expect it's US subsidiary to turnaround in FY19. Company is likely to do consolidated EPS of Rs.30 in FY18 and Rs.51 in FY19. At 20 PE the target price works out to Rs.1025.
Galaxy Surfactants Ltd – IPO Note – Issue Price 1470-1480: Galaxy Surfactants Ltd. (GSL) is one of India’s leading manufacturers of surfactants and other specialty ingredients for the personal care and home care industries. Its products find application in a host of consumer-centric personal care and home care products, including, inter alia, skin care, oral care, hair care, cosmetics, toiletries and detergent products. The diversified customer base currently comprises multinational, regional and local FMCG companies, including, inter alia, Cavinkare Private Limited, Colgate-Palmolive (India) Limited, Dabur India Limited, Henkel, Himalaya, L’ORÉAL, Procter & Gamble Home Products Private Limited, Reckitt Benckiser and Unilever. At present, it has 7 strategically-located manufacturing facilities, out of which 5 are located in India and 2 are located overseas. The company has also have set-up 1 pilot plant at Tarapur, Maharashtra, for the scaling up of new products and processes from lab-scale to plant-scale.
The company has shown consistent growth in sales as well as profitability. Personal Care and Home Cleaning are matured markets which explain the muted sales growth of 8% CAGR between FY13-17 however due to economies of scale; EBITDA grew by 22% over the same period.  We believe the valuations are fair considering the above peer group comparison considering GSL’s strong financial strength in terms of healthy return ratios, free cash flow generation and sound asset turnover ratios. At higher band the issue is offered at 35x 1HFY18 annualised earnings. We like the company’s strong position in its niche area in addition to strong pedigree of management. We recommend investors to subscribe the issue for long term gains.
Institution Desk - Biocon- SELL- 3QFY18 Result Update- Weak Operational Performance: Biocon’s revenues stood at Rs.10,579mn in 3QFY18, up  9.2%/2.8%  QoQ/YoY,  above our/consensus estimates by 4%/1%, respectively. The QoQ growth was driven by licencing income (Rs118mn vs. Rs10mn), higher biosimilar revenues (up 15.1%) Syngene’s revenues (up15.7%) and small molecule revenues (up 5.4%). Despite a large contribution from high-margin businesses (Biologics and Syngene) in overall revenues for the quarter, gross margin was adversely impacted (70bps decline) as cost of sales rose 11% QoQ as against a 9% increase in sales. It seems the biosimilar pricing is a bit subdued in emerging markets translating into lower than average company margin. Biocon capitalised Rs400mn of research and development or R&D expenditure during the quarter.
Maruti Suzuki India- ACCUMULATE - 3QFY18 Result Update- Lower Other Income And Higher Tax Rate Lead To Subdued Earnings: Maruti Suzuki India’s (MSIL) 3QFY18 earnings were below our expectations because of reduced margins, lower other income and a higher tax rate for the quarter. EBITDA margin for the quarter at 15.8% was 100bps below our estimate because of higher vehicle discount and also higher commodity prices. Average discount stood at Rs17,900/vehicle versus Rs15,200/vehicle in 2QFY18, an increase of 18% QoQ. Net sales grew 14% YoY on the back of double-digit YoY volume growth and 2% YoY realisation growth. On QoQ basis, realisation improved 0.8%. Absolute EBITDA at Rs30.3bn grew by a strong 22% YoY, while margins at 15.8% improved 100bps YoY and fell 110bps QoQ. EBITDA margin was largely impacted by higher commodity prices, which resulted in lower gross margin.
Dishman Carbogen Amcis- ACCUMULATE- 3QFY18 Result Update- Growth fundamentals intact: Dishman Carbogen Amcis’ revenues in 3QFY18 stood at Rs4,598mn, up 3.6%/27% QoQ/YoY, respectively.  Revenues were 1.3% above our estimate. Despite revenues being largely in line, net earnings were 30.1% below our estimate primarily because of a higher tax rate (38%). During the quarter the company wrote off a deferred tax asset arising out of losses at China operations. However, for the full year on a normalised basis, the tax rate for the company should be around 30%.  Not accounting for deferred tax, the current tax rate should be in the range of 20%-22% On the business front, India CRAMS business was flat QoQ because of postponement of Eprosartan revenues to the next quarter. New molecules, including the recently approved oncology molecule, witnessed growth.
Dr. Reddy’s Laboratories- BUY- 3QFY18 Result Update- The Upturn Is Still A Few Quarters Away: Dr. Reddy's Laboratories’ or DRL’s revenues at Rs38,060mn and net earnings at Rs3,344mn in 3QFY18 were above our/consensus estimates by 5.1%/3.2% and 17%/1%, respectively. During the quarter, the company also registered one-off milestone income of Rs1,200mn relating to an outlicenced asset (DFD-06) that was  largely offset by one-time deferred tax charge of Rs930mn. Going forward, in 4QFY18, there can be some temporary pressure in the US business as Renvela and Dacogen generics are likely to witness a full-quarter impact of incremental competitive pressure. New drug launches during the quarter can potentially more than offset the competitive pressure and we are eager to see how these turn around.
Indoco Remedies- ACCUMULATE - 3QFY18 Result Update- A strong quarter despite US woes: Indoco Remedies’ or IRL’s 3QFY18 revenues at Rs2,781mn and net earnings at  Rs227mn were above our /consensus estimates by 5%/1.1% and 75%/64%, respectively.  Revenues were down 2.4% QoQ and up 7.9% YoY.  The outperformance on the top-line front was largely driven by strong growth in Europe and emerging markets which grew 41% and 43%, respectively.  Net earnings outperformance was disproportionate as COGS declined 260bps QoQ and was aided by a lower tax rate.  COGS growth was driven by improvement in the product mix and is expected to sustain.
Sagar Cements- BUY- 3QFY18 Result Update- Weak Quarter, But Geared For A Better Show: Sagar Cements (SGC) reported a weak performance for 3QFY18 on account of lower-than-expected realisation impacting EBITDA margin. Realisation declined 9.5% YoY to Rs3,667/tn, which was below our estimate. The decline was because of higher volume push leading to weak cement prices in key markets like Andhra Pradesh, Telangana and Maharashtra. SGC reported a volume of 0.68mt, up 44.1% YoY (not comparable) from 0.47mt in 3QFY17, resulting in ~30.4% YoY revenue growth to ~ Rs2.5bn. Strong cost control  measures arrested SGC’s performance from a further decline as operating costs fell 6.5% YoY to Rs3,203/tn.

Wednesday, 24 January 2018

Market Insight - Dow, Dow Futures, Hangseng, SGX Nifty & Nikkei 25 Jan 17

Markets always tend to be interesting with something or the other happening all the time. Our Morning Mantra is released before the opening bell and it includes the market commentary along with Corporate & Global news for the day.

US stocks were mixed after the close on Wednesday, as gains in the Telecoms, Basic Materials and Financials sectors led shares higher while losses in the Technology, Utilities and Oil & Gas sectors led shares lower.



Dow

 

Dow Futures

Hangseng

 

Nikkei

SGX Nifty

 

26252.1

26259.0

32746.5

23723.6

11091.5

+41.3

-11.0

     -212.2

-217.2

+15.5

+0.16%

     -0.04%

-0.64%

-0.91%

+0.14%


Asian indices are mostly lower on Thursday amid concerns over trade wars, while the U.S. dollar fell following Treasury Secretary Steven Mnuchin's comments that a weaker greenback would be good for U.S. trade. Meanwhile, higher commodity prices lifted resources stocks.

Market is expected to open on flattish note and likely to remain volatile ahead of the expiry.  
PTI has reported that government is likely to impose Anti-Dumping Duty on DMF, on of the key product of Balaji Amines. Positive
Bharat Electronics to consider buyback proposal on Jan. 30.
Wipro buys minority stake in Harte Hanks for $9.9 million.

IndiGo to be awarded routes on 20 proposals, highest among all carriers, under India’s regional connectivity scheme UDAN.
Phillips Carbon to consider raising funds on Jan. 31.
Majesco unit wins contract from Reliance Nippon Life Insurance.
Dr. Reddy’s says German regulator carried out re-inspection of its Bachupally plant. It can now start dispatching products to Europe.
PNB - Adj Book Value for FY 20 works out to Rs.121 and at 1.4 X P/Adj BV The target works out to Rs.170. In Govt Re cap PNB going to get  Notional Rs.5473cr where as in recent QIP PNB raised Rs.5000cr @ Rs.168. Post QIP price remain flat. So why it should move up now.

For SBI the capital additional is very small. Over all Positive impact of Rs.5. But for long term the target price for SBI based on FY20 is Rs.405.
Utkal Alumina International Ltd, a 100% subsidiary of Hindalco Industries, has sought environment clearance to double capacity of its alumina refinery in Odisha from 1.5 million tonnes per annum (mtpa) now to 3 mtpa.The expansion estimated to cost Rs 4000-5000 crore, would be effected in phases.

Bharat Financial Inclusion assigned a pool of receivables of an aggregative value of Rs 225.77 crore to a public sector bank on direct assignment basis as per the guidelines of the Reserve Bank of India

JFE Holdings, and JSW Steel, are likely to put in a joint bid for bankrupt Bhushan Steel reflecting competitive intensity for an asset that the Tatas and Arcelor Mittal may also seek to buy to benefit from an upswing in an industry overcoming four years of supply overhang. 
Bharti Airtel has received regulatory approval to acquire Millicom International Cellular's Rwanda unit, Tigo Rwanda, which will make the Indian telco a strong No. 2 carrier by revenue in the African country. 

Nirmal Bang Retail Research-United Spirits Concall Update-The company reported decline in Sales due to change in Route-to-market in Haryana and Punjab from private retail to government route. These markets are (and probably UP and West Bengal) are shifting the model hence as a precautionary measure the company focused on cash sales from credit sales to recover dues from the retail sellers who would be out of business from April 1. Apart from the states mentioned above, the company witnessed strong sales growth. However, there could be some spillover effect in Q4 as well. Nonetheless management sounded positive and reiterated its double digit sales growth with mid to high teens EBITDA margins.
Institution desk: Crompton Greaves Consumer Electricals- ACCUMULATE- 3QFY18 Result Update- Moderate Revenue Growth But Sustains Healthy Margin: Crompton Greaves Consumer Electricals (CGCEL) posted 3QFY18 revenues of Rs9.4bn, up 7% YoY, but excise adjusted growth was 12% YoY. Top-line was 9%/6% below our/consensus estimates, respectively. While premium fans grew 28% YoY, excise adjusted revenue growth of the consumer durable segment was tepid at 7.4% YoY because of headwinds faced in pump and geyser categories. The lighting segment’s sales surged 23% YoY (aided by 57% YoY growth in LED lights). Gross margin rose 250bps YoY and 280bps QoQ to 33.1% in 3QFY18 led by premiumisation of the portfolio (premium fans & LED lights) and cost reduction programme. EBITDA margin rose 130bps YoY to 12.4%, leading to 20% YoY growth in EBITDA to Rs1.2bn, partially aided by low base. EBIT margin of the lighting segment rose 290bps YoY to the highest-ever level of 13.8% while the consumer durable segment witnessed a 210bps YoY expansion to 18.2%. PAT grew 28% YoY to Rs695mn, in line with consensus but below our estimate of Rs792mn (on account of top-line miss).
IFB Industries- BUY- Initiating Coverage- Scalability Attained, Profitability To Follow: The home appliance industry in India offers highly promising growth prospects driven by its low penetration level as well as rising demand owing to improved affordability and easy availability of consumer durable finance. IFB Industries (IFB) is favourably placed to reap the benefits of this upturn owing to its marquee brand proposition, distribution network expansion, undisputed leadership in front-load washing machines, scaling up of other categories (top-load washing machines, microwave ovens, air-conditioners) as well as the impending launch of its refrigerators. While we expect IFB to post industry-leading 23.7% revenue CAGR over FY17-FY20E, the benefits of attaining scale (better absorption of fixed-cost overheads), operating leverage and achieving cost efficiency through import substitution in front-load washing machines will lead to substantial improvement in profitability. We expect IFB to post 500bps EBITDA margin expansion over FY17-FY20E, leading to 53.2% EBITDA CAGR and 65.4% earnings CAGR over FY17-FY20E. We initiate coverage on IFB with a target price of Rs1,900 and assign Buy rating to the stock.

India Macro Meter - Economy Update- Recovery Entrenched; Interest Rates Moving Up: Data for November and December 2017 indicates that the recovery is well entrenched, after a dip in activity in October. In November 2017, 33 out of 41 indicators (80.5%) were in the positive territory, up from 57% in October 2017. The recovery sustained well into December 2017, with 84% of available indicators in the positive territory. While a favourable base on account of demonetisation has a role to play in this, the sequential momentum is also encouraging. We believe that growth in 2HFY18 is likely to be above 7%, surpassing the Central Statistical Organisation’s or CSO’s estimate. Rural recovery will require the government’s push, which we expect in the forthcoming budget, with wage growth witnessing some tapering and rabi crop sowing lagging last years’ level. Manufacturing sector’s recovery appears to be on a firm footing with the PMI for December 2017 coming in at a five- year high of 54.7. Services sector activity is chugging along with services PMI recovering to 50.9 in December 2017, after slipping into the negative territory in the previous month. The pick-up in real economic activity along with an upturn in market interest rates supports the banking sector’s credit growth.

Tuesday, 23 January 2018

Market Insight - Dow, Dow Futures, Hangseng, SGX Nifty & Nikkei 24 Jan 17

Markets always tend to be interesting with something or the other happening all the time. Our Morning Mantra is released before the opening bell and it includes the market commentary along with Corporate & Global news for the day.

US stocks were mixed after the close on Tuesday, as gains in the Utilities, Technology and Consumer Services sectors led shares higher while losses in the Telecoms, Healthcare and Oil & Gas sectors led shares lower.



Dow  26210.8  -3.8  -0.01%
Dow Futures 26200.0  -1.0  0.00%
Hangseng  32746.1  -184.6  -0.56%
Nikkei  23989.1  -135.1  -0.56%
SGX Nifty  11080.0  -8.0  -0.07%

Asian indices are trading with a negative bias. Trade concerns simmered in the background after President Donald Trump approved tariffs on imported solar cells and washing machines earlier this week.
Market is expected to open on flattish note and likely to witness range bound session during the day.  

The calendar fourth-quarter earnings season is off to a good start. As of Tuesday, 76 percent of the S&P 500 US companies that had reported surpassed earnings expectations, while 84 percent of those companies had beaten sales estimates, according to Thomson Reuters I/B/E/S.
Wipro bags multi-year business process services contract from Nilfisk.

Novelis, subisidiary of Hindalco announced that it will invest around $300 million in an automotive aluminium sheet manufacturing facility in Guthrie, Kentucky, as part of its plans to expand manufacturing for automotive purposes to meet the rising demand. 
After the conclusion of the promoter's stake sale in its rental arm to Singapore sovereign wealth fund GIC, DLF is looking to make its development arm a zero net-debt company by March 2019, repaying the entire liability of Rs 13,000 cr. 
Manappuram Finance board authorises managing director to scout for investment opportunity.

Majesco QIP opens with a floor price of Rs 532 per share.
eClerx Services to buyback shares Worth Rs 258 cr at Rs 2000/ share.The total number of shares to be bought back in the buyback shall be 12,90,000 equity shares representing about 3.24% of the total issued and paid up equity share capital as on 31 March 2017.
Genus Paper & Boards Ltd, has taken on lease a Kraft paper manufacturing facility for 5 Years. The facility is located at Kashipur, Uttarakhand and has manufacturing capacity of 75,000 metric tonnes per annum (MTPA).

Lenders to Amtek Auto, which is facing Rs 12,722-crore claims from creditors, have decided to reject the only two offers they received — from Liberty House and Deccan Value Investors — unless the bidders raised the price. The offers are below the liquidation value of the company. 
Arcelor Mittal has withdrawn from bidding for bankrupt Bhushan Power & Steel after it conducted due diligence on the Indian company. Tata Steel, JSW, Vedanta, AION Capital and a Dubai-based billionaire remain in the fray for the bankrupt company ahead of the January 29 deadline. 

Alembic to buy back 1.02 crore shares (3.84% equity) at Rs 80 per share.
Quickheal Technologies receives order from tax authorities demanding Rs 37.7 crore. Company will appeal against the order with CESTAT.
Retail Research desk: DHFL Concall Update –AUM crossed Rs. 1 Lac cr (Rs 1,01,286 cr) increased 29% YoY (8% QoQ).AUM Mix was stable QoQ: Home Loans 63%, LAP 18%, Project 15%, SME 4%.Disbursements increased by 54% YoY to Rs. 10,846 cr, (+9% QoQ).Disbursement mix: Home Loans 55%, LAP 21%, Project 18%, SME 8%.Sanctions increased by 75% YoY to Rs. 16,552 cr.NII came at Rs. 739.8 Cr vs YoY (+31%) Rs. 566.4 Cr, QoQ (+4%) Rs. 710.8 Cr.PAT came at Rs. 306 Cr vs YoY (+25%) Rs. 244.8 Cr, QoQ (+4%) Rs. 293.3 Cr. Incremental yields for Home Loans at 9.3%, for LAP at 11.3%.Incremental Cost of Funds at 7.95%.Cost/Income of 23.04% has been consistently declining. Scope for further reduction of 100-150bp. It will always be higher than peers (~17%) as company’s distribution reach is focused on tier2/3 towns which involves a higher cost structure. Asset quality stable QoQ/YoY: GNPA at 0.96%, NNPA at 0.54%.ROE is stable at 17.8% (adjusting for stake sale of DPLI by DHFL).Affordable housing to drive growth in housing loan market. Company held 23 events in tier2/3 segments during the quarter. Company’s strength lies in its reach in tier 2/3 towns. Won’t need to raise capital for next 2 years (CAR of 16.3%). Growth Guidance for next couple of years: AUM / Disbursements / PAT is 20-24% / 27-30% / 20-24%.Share is trading at P/E of 17x FY18E EPS & 2.2x trailing P/BV

Institution desk: V-Guard Industries- ACCUMULATE- 3QFY18 Result Update- Sustains Strong Revenue Growth; Retain Accumulate: V-Guard Industries (VIL) posted strong 3QFY18 revenues of Rs5.2bn, up 19% YoY, in line with consensus estimate but marginally below our estimate of Rs5.4bn. Adjusted for GST-related price change impact, the revenue growth was even stronger at 23% YoY. The growth was broad-based across all product categories led by cables & wires, inverters and fans. Gross margin improved 160bps YoY to 32.4% while EBITDA margin rose 120bps YoY to 9.4%, leading to 37% YoY increase in EBITDA to Rs494mn. PAT jumped 41% YoY to Rs358mn, partly led by a lower tax rate of 23.4% (versus 27.2% YoY). The bottom-line was below our estimate of Rs396mn, but above consensus estimate by 4%. EBITDA margin in 9MFY18 stood at 9.1%, but the management aims to achieve EBITDA margin of 10% in FY18 driven by a seasonally strong fourth quarter. We have marginally tweaked our earnings estimates and rolled forward our valuation to FY20E financials. We have retained Accumulate rating on VIL with a revised target price of Rs240 (Rs210 earlier) based on 36x FY20E earnings.